Growth Requirements
These rules favor companies still compounding revenue, earnings, or cash flow at a meaningful pace.
- EPS Growth (TTM) ≥ 25%
- Revenue Growth (1Y) ≥ 20%
Stock screen focused on companies matching EPS Growth (TTM) ≥ 25%, RS Rating ≥ 80, % from 52W High ≥ 90%, and Revenue Growth (1Y) ≥ 20%.
High EPS Growth High Revenue Growth High RS Rating Near 52-Week High Stocks narrows the universe by combining growth requirements, technical confirmation. This creates a more opinionated list than a simple single-metric stock screen.
These rules favor companies still compounding revenue, earnings, or cash flow at a meaningful pace.
These conditions use price structure and relative-position signals to confirm trend quality.
| Ticker | Company | Price | Mkt Cap | EPS Growth TTM | RS Rating | % of 52W High | Rev Growth 1Y |
|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $309.93 | $44.39B | +28.8% | 91.0 | 95.6% | +35.9% |
| MDB | MongoDB, Inc. | $460.33 | $37.03B | +67.13% | 91.0 | 97.3% | +22.79% |
| RBRK | Rubrik, Inc. | $102.23 | $21.04B | +48.55% | 95.0 | 96% | +48.46% |
| FIVE | Five Below, Inc. | $244.54 | $13.52B | +66.04% | 81.0 | 97.2% | +22.9% |
| FROG | JFrog Ltd. | $96.17 | $11.65B | +52.1% | 94.0 | 96.9% | +24.12% |
| JXN | Jackson Financial Inc. | $135.32 | $9.44B | +500% | 83.0 | 98.1% | +116.14% |
| PRMB | Primo Brands Corporation | $24.70 | $8.96B | +337.2% | 80.0 | 94.2% | +29.34% |
| OSCR | Oscar Health, Inc. | $32.76 | $8.49B | +284.21% | 96.0 | 98.5% | +27.5% |
| COMP | Compass, Inc. | $13.02 | $7.92B | +203.87% | 91.0 | 93.3% | +23.67% |
| AVT | Avnet, Inc. | $95.71 | $7.85B | +46.8% | 89.0 | 95.7% | +24.47% |
| S | SentinelOne, Inc. | $23.11 | $7.78B | +27.27% | 95.0 | 96.5% | +21.89% |
| VCTR | Victory Capital Holdings, Inc. | $118.24 | $7.39B | +34.32% | 94.0 | 99.5% | +46.19% |
| GLBE | Global-e Online Ltd. | $42.36 | $7.12B | +609.96% | 83.0 | 96.3% | +27.82% |
| HNGE | Hinge Health, Inc. | $88.49 | $6.85B | +122.11% | 97.0 | 95% | +50.58% |
| ZETA | Zeta Global Holdings Corp. | $29.05 | $6.55B | +95.26% | 94.0 | 97.2% | +29.72% |
| LGND | Ligand Pharmaceuticals Incorporated | $294.60 | $5.9B | +333.75% | 89.0 | 90.2% | +60.4% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $76.75 | $5.85B | +2350% | 95.0 | 92.5% | +60.09% |
| HRI | Herc Holdings Inc. | $173.51 | $5.8B | +68.97% | 82.0 | 92.1% | +22.65% |
| TVTX | Travere Therapeutics, Inc. | $62.14 | $5.78B | +75.98% | 95.0 | 93.8% | +110.45% |
| RELY | Remitly Global, Inc. | $26.30 | $5.54B | +2206.14% | 95.0 | 96.9% | +29.37% |
| PAY | Paymentus Holdings, Inc. | $41.86 | $5.26B | +53.49% | 95.0 | 92.4% | +37.25% |
| APLS | Apellis Pharmaceuticals, Inc. | $41.03 | $5.25B | +159.22% | 95.0 | 99.8% | +28.46% |
| XMTR | Xometry, Inc. | $96.26 | $5.18B | +51.22% | 93.0 | 90.8% | +25.87% |
| MRX | Marex Group Limited | $71.06 | $5.11B | +69.74% | 91.0 | 94.2% | +25.39% |
| TPC | Tutor Perini Corporation | $96.82 | $5.11B | +191.97% | 83.0 | 94.6% | +28.11% |